CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-01 | LOSCALZO JOSEPH Director | Grant or award · Restricted Stock Unit | +5,220 | 9,299 | ||
| 2025-07-01 | KLEIN JOSEPH III Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,518 | 11,518 | ||
| 2025-07-01 | KLEIN JOSEPH III Director | Grant or award · Restricted Stock Unit | +5,220 | 13,976 | ||
| 2025-07-01 | HERMAN JOAN E Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,518 | 11,518 | ||
| 2025-07-01 | HERMAN JOAN E Director | Grant or award · Restricted Stock Unit | +5,220 | 9,299 | ||
| 2025-07-01 | Hayden Michael R Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,518 | 11,518 | ||
| 2025-07-01 | Hayden Michael R Director | Grant or award · Restricted Stock Unit | +5,220 | 13,976 | ||
| 2025-07-01 | Diaz Allene M. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,518 | 11,518 | ||
| 2025-07-01 | Diaz Allene M. Director | Grant or award · Restricted Stock Unit | +5,220 | 9,299 | ||
| 2025-07-01 | BERTHELSEN SPENCER R Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,518 | 11,518 | ||
| 2025-07-01 | BERTHELSEN SPENCER R Director | Grant or award · Restricted Stock Unit | +5,220 | 9,299 | ||
| 2025-05-01 | Hayden Michael R Director | Purchase | +15,000 | $31.86 | $478K | 50,219 |
| 2025-04-16 | Birchler Brian EVP, Corp and Development Ops | Sale | −680 | $28.37 | $19K | 56,660 |
| 2025-04-16 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Sale | −3,016 | $28.36 | $86K | 11,199 |
| 2025-04-16 | Baroldi Joseph EVP, Chief Business Officer | Sale | −3,928 | $28.40 | $112K | 31,926 |
| 2025-04-15 | Birchler Brian EVP, Corp and Development Ops | Option exercise | +1,875 | 57,340 | ||
| 2025-04-15 | Birchler Brian EVP, Corp and Development Ops | Option exercise · Restricted Stock Unit | −1,875 | 61,215 | ||
| 2025-04-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Option exercise | +12,226 | 14,215 | ||
| 2025-04-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Option exercise · Restricted Stock Unit | −12,226 | 36,677 | ||
| 2025-04-15 | Baroldi Joseph EVP, Chief Business Officer | Option exercise | +10,837 | 35,854 |
Page 30 of 34 · 668 trades